Key Highlights

  • Synertec identified ANSTO as the client behind its AUD 45.5mn engineering contract.
  • The initial 26-month design phase is expected to generate about AUD 36mn in revenue.
  • The company will manage process design and facility-wide design integration.
  • The approximately eight-year program supports a new Manufacturing Facility at Lucas Heights.

Synertec Corporation Limited (ASX:SOP) has detailed the client, Economics and responsibilities behind a previously announced engineering award. The AUD 45.5mn engagement places the company in a lead design and integration role for a new nuclear-medicine manufacturing facility being delivered for the Australian Nuclear Science and Technology Organisation at Lucas Heights.

Engineering Scope Reaches across the Facility

Synertec will lead process design and coordinate design integration across the facility. Its responsibilities include process architecture, engineering, specialised good-manufacturing-practice and radiological systems, utilities, systems engineering and interface management. The company will also support procurement, vendors, regulation, licensing, digital engineering, construction, commissioning, qualification and readiness for operations.

The First Phase Carries Most of the Revenue

The program is expected to run for about eight years. Synertec anticipates approximately AUD 36mn of Revenue during the initial 26-month design phase, which begins on 21 September 2026. The full AUD 45.5mn contract equals 2.4 times the engineering division’s FY26 external revenue. Management expects a project contribution Margin above 25%, subject to its delivery and cost assumptions.

Payment Structure Supports the Plan

Under the contracted payment profile and current program, Synertec expects the assignment to remain cumulatively cash-flow positive for more than 90% of its duration. It also anticipates limited working-capital needs, supported by available Debt headroom and its recent Equity raising. These expectations depend on staffing, milestone performance, cost control and the timing of revenue recognition.

Mobilisation Opens the Execution Phase

Recruitment, mobilisation and early design deliverables will provide the first evidence of progress. The long duration introduces exposure to changing scope, licensing requirements, labour availability, subcontractor costs and interface complexity. Later phases will depend on the wider facility schedule across procurement, construction, qualification and commissioning. Synertec is assessing the contract’s impact on FY27 guidance and intends to update the market when recognition milestones are clearer.

A Material Addition to Engineering Work

The appointment expands Synertec’s activity in regulated infrastructure and nuclear medicine. Its contribution will depend on delivering integrated designs, meeting compliance requirements and converting the payment schedule into the expected margins and cash performance. The next useful information will come from mobilisation, guidance and progress through the initial design phase.